PTK2B and chronic myelogenous leukemia, BCR-ABL1 positive: PTK BCR-ABL1 is not expressed in healthy organisms because it is a product of cellular deregulation, and this PTK has been described as an oncogene that is present in 95% of patients with chronic myeloid leukemia (CML) [4].